Cooley's London office has picked up life sciences duo John Wilkinson and Nicola Maguire from Reed Smith. The two, who have worked together for many years, are among the first partner additions to Cooley’s London office since its 20-partner January launch. 'John and Nicola are two of the UK’s most highly talented life sciences lawyers,' said Justin Stock, managing partner of Cooley’s London office. 'Their practice areas and client bases complement many of Cooley’s core strengths and they will add to the incredible momentum we’ve experienced here in London since day one. Cooley’s tech and life sciences brand is known throughout the world and we are excited to be further strengthening it here in the UK.'

Pharma background

John Wilkinson’s practice focuses primarily on advising specialty pharma, biotech and medical technology companies on a wide range of transactional, IP, regulatory and antitrust matters. Prior to qualifying as a lawyer, Wilkinson worked for five years as a chemist doing drug development. He advises clients from around the world, including continental Europe and the United States and numerous clients in Scandinavia. Nicola Maguire specialises in advising life sciences companies and other IP-rich clients at all stages of development, from startups to listed companies, on collaborations, M&A, joint ventures and other negotiated transactions. Many of the deals on which she advises have a cross-border component, often involving parties in Europe, the United States and India.

Background

Cooley opened its London office in January with more than 55 lawyers and other professionals. On March 9, it announced the arrival of private equity and venture capital partner Stephen Rosen, who will join from Olswang.